No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 54,162 | 80,782 | 87,449 | 54,272 | 52,925 | 47,318 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 307 | 2,154 | 1,311 | -1,848 | -2,837 | -2,223 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Operating globally, Sinochem International Corporation specializes in a diverse portfolio encompassing advanced materials, agricultural chemicals, polymer enhancement additives, and natural rubber production. Within its new materials division, the company provides a range of innovative products such as polycarbonates, polystyrenes, dyed pigments, ABS resins, polyurethanes, and forest greases. It also supplies thermoplastics crucial for the automotive, medical, electrical equipment, and electronic engineering sectors, alongside high-performance fibers. Furthermore, Sinochem International manufactures advanced membrane technologies—including reverse osmosis, nanofiltration, degassed, and electro-driven ionic membranes—utilized across a broad spectrum of water treatment applications, from zero liquid discharge and wastewater recycling to seawater desalination, brackish water treatment, ultrapure water production, and general domestic water purification. The firm's offerings extend to various polymer additives, including rubber antioxidants, insoluble sulfur, vulcanizing accelerators for rubber, and nitrobenzene. Moreover, it is a key supplier of lithium battery materials, serving the portable electronics, power tool, and New Energy Vehicle (NEV) industries, in addition to producing EV battery cells specifically for electric vehicles. Beyond materials, Sinochem International delivers a suite of agricultural chemicals and comprehensive solutions designed to boost crop yield and quality for farmers. These include active pharmaceutical ingredients (APIs), specialized preparations, advanced fine chemical intermediates, herbicides, pesticides, and fungicides. The company is also active in the healthcare sector, engaging in the research, production, and distribution of medical equipment, raw nutritional ingredients, and food additives. Its medical focus spans pharmaceuticals and devices tailored for orthopedics, cardiology, gastroenterology, and neurosurgery. Furthermore, it manages the production and commercialization of natural rubber. To support its diverse operations, Sinochem International maintains a network of production facilities for intermediates and new materials, alongside state-of-the-art laboratories and extensive analysis and testing centers. Established in 1998, the corporation is headquartered in Shanghai, People's Republic of China, and functions as a subsidiary of Sinochem Corporation.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Sinochem International Corporation (600500.SS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Operating globally, Sinochem International Corporation specializes in a diverse portfolio encompassing advanced materials, agricultural chemicals, polymer enhancement additives, and natural rubber production. Within its new materials division, the company provides a range of innovative products such as polycarbonates, polystyrenes, dyed pigments, ABS resins, polyurethanes, and forest greases. It also supplies thermoplastics crucial for the automotive, medical, electrical equipment, and electronic engineering sectors, alongside high-performance fibers. Furthermore, Sinochem International manufactures advanced membrane technologies—including reverse osmosis, nanofiltration, degassed, and electro-driven ionic membranes—utilized across a broad spectrum of water treatment applications, from zero liquid discharge and wastewater recycling to seawater desalination, brackish water treatment, ultrapure water production, and general domestic water purification. The firm's offerings extend to various polymer additives, including rubber antioxidants, insoluble sulfur, vulcanizing accelerators for rubber, and nitrobenzene. Moreover, it is a key supplier of lithium battery materials, serving the portable electronics, power tool, and New Energy Vehicle (NEV) industries, in addition to producing EV battery cells specifically for electric vehicles. Beyond materials, Sinochem International delivers a suite of agricultural chemicals and comprehensive solutions designed to boost crop yield and quality for farmers. These include active pharmaceutical ingredients (APIs), specialized preparations, advanced fine chemical intermediates, herbicides, pesticides, and fungicides. The company is also active in the healthcare sector, engaging in the research, production, and distribution of medical equipment, raw nutritional ingredients, and food additives. Its medical focus spans pharmaceuticals and devices tailored for orthopedics, cardiology, gastroenterology, and neurosurgery. Furthermore, it manages the production and commercialization of natural rubber. To support its diverse operations, Sinochem International maintains a network of production facilities for intermediates and new materials, alongside state-of-the-art laboratories and extensive analysis and testing centers. Established in 1998, the corporation is headquartered in Shanghai, People's Republic of China, and functions as a subsidiary of Sinochem Corporation.
